Ratings Cardlytics, Inc.

Equities

CDLX

US14161W1053

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
9.27 ^USD	-36.51%		-33.64%	+0.65%

May. 09	Craig-Hallum Adjusts Cardlytics Price Target to $12 From $18, Maintains Buy Rating	MT
May. 09	Needham Adjusts Price Target on Cardlytics to $12 From $17, Keeps Buy Rating	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

Sales forecast by analysts have been recently revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Over the past four months, analysts' average price target has been revised upwards significantly.
The opinion of analysts covering the stock has improved over the past four months.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
The company is highly valued given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
CARDLYTICS, INC.	+0.65%	447M	D+
MICROSOFT CORPORATION	+9.65%	3,064B	C+
SYNOPSYS INC.	+6.79%	83.88B	B
CADENCE DESIGN SYSTEMS, INC.	+4.74%	77.63B	B+
DASSAULT SYSTÈMES SE	-13.51%	53.97B	B+
PALANTIR TECHNOLOGIES INC.	+23.12%	47.08B	D+
ATLASSIAN CORPORATION	-24.39%	46.81B	B-
THE TRADE DESK, INC.	+23.22%	43.34B	D+
SEA LIMITED	+62.94%	37.9B	D+
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-9.49%	24.85B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes